throbber
Page 1
`
` UNITED STATES PATENT AND TRADEMARK OFFICE
` BEFORE THE PATENT TRIAL AND APPEAL BOARD
` ------------------------------------------------
` MEDTRONIC, INC., and
` MEDTRONIC VASCULAR, INC.,
`
` Petitioners,
`
` vs.
`
` TELEFLEX INNOVATIONS S.A.R.L.,
` Patent Owner.
` ------------------------------------------------
` IPR2020-00126 (Patent 8,048,032 B2)
` IPR2020-00127 (Patent 8,048,032 B2)
` IPR2020-00128 (Patent RE45,380 E)
` IPR2020-00129 (Patent RE45,380 E)
` IPR2020-00130 (Patent RE45,380 E)
` IPR2020-00132 (Patent RE45,760 E)
` IPR2020-00134 (Patent RE45,760 E)
` IPR2020-00135 (Patent RE45,776 E)
` IPR2020-00136 (Patent RE45,776 E)
` IPR2020-00137 (Patent RE47,379 E)
` IPR2020-00138 (Patent RE47,379 E)
`
` VIDEO EXPERT DEPOSITION TRANSCRIPT OF
` RICHARD A. HILLSTEAD, PH.D
` FRIDAY, SEPTEMBER 11, 2020
` JASPER, GEORGIA
`
`1
`2
`3
`4
`
`5
`
`6
`
`7 8
`
`9
`10
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`17
`18
`19
`20
`21
`
`22
`
`23
`24
`25
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`888-391-3376
`
`

`

`Page 2
`
`Page 4
`
`1 APPEARANCES (continued):
`2 CARLSON, CASPERS, VANDENBURGH &
`3 LINDQUIST
`4 BY: PETER M. KOHLHEPP, ESQUIRE
`5 pkohlhepp@carlsoncaspers.com
`6 J. DEREK VANDENBURGH, ESQUIRE
`7 dvandenburgh@carlsoncaspers.com
`8 JOSEPH W. WINKELS, ESQUIRE
`9 jwinkels@carlsoncaspers.com
`10 Suite 4200
`11 225 South Sixth Street
`12 Minneapolis, Minnesota 55402
`13 612.436.9600
`14 Counsel for Patent Owner
`15 Also Present:
`16 Greg Smock and Howard Cyr, Teleflex
`17 Andrew Weber, videographer
`18 * * *
`19
`20
`21
`22
`23
`24
`25
`
`1 * * *
`
`2 3
`
` Video Expert Deposition Transcript of
`4 RICHARD A. HILLSTEAD, PH.D. taken via remote
`5 communication at 3 Lukes Path, Jasper, Georgia
`6 on Friday, September 11, 2020, commencing at
`7 9:00 a.m. before Rebecca L. Klanderud, a
`8 Certified Shorthand Reporter.
`9
`10
`11
`12
`13 * * *
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`Page 3
`
`Page 5
`
`1 APPEARANCES:
`2 ROBINS KAPLAN, LLP
`3 BY: CHRISTOPHER A. PINAHS, ESQUIRE
`4 cpinahs@robinskaplan.com
`5 CYRUS A. MORTON, ESQUIRE
`6 cmorton@robinskaplan.com
`7 SHELLEY R. GILLIS, PH.D.
`8 sgillis@robinskaplan.com
`9 Suite 2800
`10 800 LaSalle Avenue
`11 Minneapolis, Minnesota 55401
`12 612.349.8500
`13 Counsel for the Petitioners
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
`1 INDEX:
`2 EXAMINATION: PAGE
`3 By Mr. Kohlhepp . . . . . . . . . . . . . 7
`4 * * *
`5 EXHIBITS:
`6 HILLSTEAD EXHIBITS: PAGE MARKED
`7 Exhibit 1042-135 Binder book marked CV
`8 and Declaration of
`9 Richard A. Hillstead 83
`10 * * *
`11 EXHIBITS:
`12 PREVIOUSLY MARKED EXHIBITS: PAGE MENTIONED
`13 Exhibit 1007 Itou patent 69
`14 Exhibit 1008 Ressemann reference 115
`15 Exhibit 1050 Enger patent 221
`16 Exhibit 2085 Figure 16D from the
`17 Ressemann patent 134
`18 Exhibit 2086 Drawing 170
`19 * * *
`20
`21
`22
`23
`24
`25
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`2 (Pages 2 - 5)
`888-391-3376
`
`

`

`Page 6
`1 THE VIDEO TECHNICIAN: This is the
`2 11th day of September 2020. The time is 9:16
`3 Central Daylight Time.
`4 This is the videotaped deposition of
`5 Richard Hillstead in the matter of Medtronic,
`6 Inc., et al. versus Teleflex Innovations,
`7 S.A.R.L.
`8 My name is Andrew Weber, the
`9 videographer, representing Veritext Midwest.
`10 Would the attorneys please announce
`11 their appearances for the record?
`12 MR. KOHLHEPP: This is Peter Kohlhepp
`13 on behalf of the patent owner, Teleflex.
`14 Also, with me today is Derek
`15 Vandenburgh and Joe Winkels, and all three of us
`16 are with the Carlson Caspers law firm.
`17 Also, online I believe are Howard Cyr
`18 and Greg Smock of Teleflex.
`19 MR. PINAHS: This is Chris Pinahs on
`20 behalf of the petitioner, Medtronic.
`21 Also, here today is Cy Morton and
`22 Shelley Gillis of the Robins Kaplan law firm as
`23 well.
`24 MR. KOHLHEPP: Good morning, Dr.
`25 Hillstead.
`
`Page 8
`
`1 full name for the record, please?
`2 A. Yes. Richard Averill Hillstead.
`3 Q. What is your address?
`4 A. 3 Lukes Path, that's Luke as in
`5 Skywalker, and path, walk the path, Jasper,
`6 Georgia 30143.
`7 Q. Okay. And we'll just go over a few
`8 reminders here at the beginning of the
`9 deposition.
`10 Um, you're aware that you're
`11 testifying under your oath today, correct?
`12 A. Boy, I am really having trouble
`13 hearing you. I heard you say you are aware
`14 of . . .
`15 Q. You're aware that you're testifying
`16 under oath today, correct?
`17 A. Yes.
`18 Q. Okay. Do you have an understanding
`19 of why you're here today?
`20 A. Uh, yes. My understanding is to
`21 provide expert testimony regarding the -- the
`22 product at hand, as well as the field of
`23 interventional cardiology devices. Um, I think
`24 my role here is to help instruct the -- the PTAB
`25 panel, the attorneys, and anyone else involved
`
`Page 7
`1 THE VIDEO TECHNICIAN: And would the
`2 court reporter please swear in the witness?
`3 THE COURT REPORTER: Dr. Hillstead,
`4 please raise your right hand, sir.
`5 THE WITNESS: I'm sorry.
`6 Could you repeat that?
`7 THE COURT REPORTER: Dr. Hillstead,
`8 please raise your right hand, sir.
`9 DR. HILLSTEAD: Oh, yes. Okay.
`10 * * *
`11 RICHARD HILLSTEAD,
`12 a witness in the above-entitled matter,
`13 having been first duly sworn,
`14 testified on his oath as follows:
`15 * * *
`16 EXAMINATION
`17 * * *
`18 BY MR. KOHLHEPP:
`19 Q. Good morning, Dr. Hillstead.
`20 A. Good morning.
`21 Q. Thanks for your patience as we get
`22 this remote, um, process set up. I know it's
`23 not quite as straightforward as it would be in
`24 person.
`25 Could you go ahead and state your
`
`Page 9
`
`1 as to what a person of skill in this field in
`2 interventional cardiology devices, um, would
`3 know about the subject matter.
`4 Q. And you mentioned the product at
`5 issue.
`6 What product is that?
`7 A. You say I mentioned products, and
`8 what product?
`9 Q. Correct.
`10 A. Well, we're talking about the guide
`11 extension catheter. We're talking about the --
`12 several products here involved. Um, there are
`13 multiple patents that resulted in products, so a
`14 number of products.
`15 Q. Okay. I think we'll get into that a
`16 little bit further in a moment.
`17 A. Okay.
`18 Q. So as your counsel has probably
`19 informed you, I'm going to be asking you a
`20 series of questions today, and it's important
`21 that we don't talk over each other.
`22 Particularly, because we're doing this remotely,
`23 it's a little bit more difficult, so --
`24 A. Um-huh.
`25 Q. -- I would just ask that you try to
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`3 (Pages 6 - 9)
`888-391-3376
`
`

`

`Page 10
`
`1 let me finish my question before you start to
`2 answer. I will try to do the same, and let you
`3 finish your answer before I start another
`4 question.
`5 A. Good.
`6 Q. And as Mr. Pinahs mentioned, given
`7 our -- our audio issues, definitely let me know
`8 if you don't understand a question or can't hear
`9 me. Um, feel free to just wave or -- or say
`10 something if you didn't hear what I'm saying.
`11 A. I will. Thank you.
`12 Q. Uh, we can take breaks throughout the
`13 deposition. I will -- I will probably try to
`14 take a break about every hour but if you need a
`15 break other than that, feel free to ask, and we
`16 can definitely take a short break. I would just
`17 ask that you first answer the question that I've
`18 asked before we take that break.
`19 A. Very good.
`20 And -- and let me apologize in
`21 advance. Since I'm doing this from my dining
`22 room, and I'm expecting multiple deliveries
`23 today, and I have a dog that might bark because
`24 she needs to go out, my apologies for
`25 interruptions that come up, but it's just the --
`
`Page 12
`1 guide extension product called the GuideLiner?
`2 A. The GuideLiner? Yes.
`3 Q. And were you familiar with that
`4 product when Robins Kaplan first contacted you?
`5 A. I have had familiarity with guide
`6 extension catheters. However, I'm not -- I'm
`7 not all that good on the names of them from a
`8 marketing perspective, um, but over the -- the
`9 last sev- -- many years, a decade or more, I'm
`10 familiar with the -- the concept and products
`11 that are related to extending the reach of
`12 guiding catheters.
`13 Q. Okay. But you don't remember if you
`14 are specifically familiar with the -- the
`15 GuideLiner product?
`16 A. GuideLiner is definitely a name I --
`17 I have heard, and, um, but I -- I would not say
`18 that I've -- I spent a lot of time studying the
`19 GuideLiner device prior to this case.
`20 Q. Okay. But you're fairly certain that
`21 you've at least heard the name GuideLiner prior
`22 to being retained in these matters?
`23 A. Yes, definitely.
`24 Q. Prior to being retained in these
`25 matters, were you familiar with any other guide
`
`Page 11
`
`Page 13
`
`1 uh, the nature of things right now.
`2 Q. Sure, and I appreciate that.
`3 Uh, Dr. Hillstead, who retained you
`4 in these IPR matters?
`5 A. Um, the firm of Robins Kaplan.
`6 Q. Do you remember when you were first
`7 approached about these matters?
`8 A. It was about a year ago. Um, I don't
`9 recall exactly what the first contact was,
`10 whether it was -- um, who -- who made the first
`11 call, I don't really recall.
`12 Q. Was it an attorney from Robins
`13 Kaplan?
`14 A. I believe so. Um, I'm pretty sure it
`15 was -- um, I think it was probably Sherry Roberg
`16 [sic] was the first person to contact me.
`17 Q. Had you work with the Robins Kaplan
`18 law firm prior to this?
`19 A. I don't believe so. I don't recall
`20 specifically working with them, certainly not
`21 the -- um, the Minneapolis -- well, I don't
`22 know. That might be their only office. I don't
`23 know, but I have not worked with any of the
`24 folks there before.
`25 Q. Are you currently familiar with the
`
`1 extension products?
`2 A. I'm going to have to ask you to
`3 repeat that.
`4 You said prior to retained in this
`5 device that . . .
`6 Q. Prior to being retained in these
`7 matters --
`8 A. Um-huh.
`9 Q. -- were you familiar with any other
`10 guide extension products other than the
`11 GuideLiner?
`12 A. Uh, yes, but, again, my familiarity
`13 wouldn't be the same as, for instance, a
`14 physician who routinely uses them. Um,
`15 GUIDEZILLA sticks out in my mind because it's a
`16 catchy name, um, and I think -- um, I know there
`17 are others. That's the only one that comes to
`18 mind at the moment namewise.
`19 Q. And you're aware that these
`20 proceedings challenge, uh, five patents,
`21 correct?
`22 A. I think that's the number, yeah, five
`23 patents. I believe you're correct.
`24 Q. And you're aware that they all
`25 pertain to Teleflex's GuideLiner product?
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`4 (Pages 10 - 13)
`888-391-3376
`
`

`

`Page 14
`
`Page 16
`
`1 A. That is my understanding.
`2 Q. Okay. So if I use the term
`3 "GuideLiner patents," you'll understand that to
`4 be referring to the five patents that are at
`5 issue in this proceeding?
`6 A. Well, I'll -- I'll understand that
`7 now that you've told me that, so I'll accept
`8 that, yes.
`9 Q. Fair enough. I just wanted to make
`10 sure we're on the same page as we're talking
`11 about things.
`12 A. We are now. Thank you.
`13 Q. Okay. So let's go back about a year
`14 ago when Robins Kaplan first contacted you.
`15 A. Um-huh.
`16 Q. Um, what was the first thing you did
`17 that you recall after they contacted you about
`18 these matters?
`19 A. What was the first thing I did after
`20 they contacted me?
`21 Q. Sure.
`22 Did you review the patents?
`23 Did you go do some online research?
`24 What did you do?
`25 A. Well, literally, the first thing I
`
`1 some sort. And, uh, during that time, there
`2 probably would have been a ramp of exchange of
`3 information, but I don't recall exactly the
`4 sequence over a year ago.
`5 Q. So would it be accurate to say that
`6 the first documents you reviewed regarding this
`7 matter were the GuideLiner patents themselves?
`8 A. Probably would have been something
`9 more like a complaint or a -- something along
`10 those lines, but, typically, when I'm retained
`11 in a case like this, those -- um, those
`12 documents, those exhibits, those things that
`13 we're going to use in the case start arriving
`14 almost simultaneously.
`15 And forgive me if I -- if I don't
`16 have a step-by-step, hour-by-hour, day-by-day
`17 recollection of which document I looked at first
`18 and second, and so on, but it would be fair to
`19 say that early on in my association with this
`20 case, I looked at those.
`21 Q. And by "those," you mean the
`22 GuideLiner patents?
`23 A. Well, that's what you were asking me
`24 about, so "those," I do mean GuideLiner patents,
`25 yes.
`
`Page 15
`
`Page 17
`
`1 did was, uh, return the call on my answering
`2 machine because that was the first communication
`3 was: Dr. Hillstead, we'd like to talk to you
`4 about this.
`5 And so I called back, and they gave
`6 me a little more, um, background on it. We did
`7 conflict checks, and so on, and then we said:
`8 Let's consider moving forward.
`9 Um, I don't know if exactly at the
`10 same time -- that would have been when they
`11 probably sent me the patents-in-suit or perhaps
`12 -- um, oh, you know, I may have gone online and
`13 searched for any sort of, um, legal activity
`14 about it. I do that often. If somebody calls
`15 me out of the blue with a case, I'll go to one
`16 of the online patent information people, whether
`17 it's Knobbe Marten or Martens or any of the --
`18 uh, and I can't -- I don't remember the names of
`19 them now, but there's multiple different sort of
`20 patent groups out there that provide newsletters
`21 and information on PTAB filings, as well as
`22 court filings. So I probably looked for
`23 something there.
`24 And then very shortly after that, we
`25 probably discussed, um, a retaining letter of
`
`1 Q. So you -- also, in your declarations
`2 that you put together, you rely on several
`3 other, uh, patents and printed publications.
`4 Is that right?
`5 A. Yes, that is correct.
`6 Q. Okay. So what -- what I'd like to
`7 find out is: How were those identified?
`8 Did you find them yourself, or did
`9 the Robins Kaplan send them to you?
`10 A. Well, when -- when you say
`11 "identified," you mean how were they brought to
`12 -- to light in the case?
`13 How were they found and brought into
`14 our -- our intent to look at them and use them?
`15 Q. How were they brought to your
`16 attention?
`17 A. That would have been a very
`18 collaborative effort. As -- as I'm sure you're
`19 well aware, there's -- this is a large bunch of
`20 IPRs and a lot of things going on here, so there
`21 would have been, um, both my research and my own
`22 history in this area, as well as the attorneys
`23 at Robins Kaplan who would be looking for the
`24 appropriate prior art.
`25 Q. Do you recall any specific pieces of
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`5 (Pages 14 - 17)
`888-391-3376
`
`

`

`Page 18
`
`Page 20
`
`1 prior art that you rely on that you yourself
`2 found through your own research?
`3 A. No. I would not have -- uh, have
`4 made a note of that either mentally or -- um, or
`5 written or anything because that -- because,
`6 frankly, I didn't expect a question like this.
`7 You know, it's not as if, um,
`8 somebody takes credit while we're all doing the
`9 research. As you well know, you've probably got
`10 a team of attorney and if we're together in a
`11 room and we all have our laptops and we're all
`12 talking about a subject, and, you know, I might
`13 be on the PTAB database, somebody else might be
`14 doing Google patents or someone else may be --
`15 Q. Sure.
`16 A. -- somewhere.
`17 Q. Right.
`18 A. So I do not specifically remember.
`19 Q. Okay. Fair enough.
`20 So what I'm really asking about is
`21 the -- the main references that you relied on,
`22 so let's just very briefly talk about them.
`23 The Itou reference, you're familiar
`24 with that?
`25 A. I missed -- I missed the second part
`
`1 the prior art, uh, database there. I don't
`2 recall if I saw it first or if it was handed to
`3 me or if it was brought up in a meeting where we
`4 were all looking for prior art. I just don't
`5 recall.
`6 Q. How about the Ressemann reference?
`7 Was that something you found yourself
`8 or something Robins Kaplan gave you?
`9 A. Did you say Ressemann?
`10 Q. I did say Ressemann, yes.
`11 A. Okay. This is probably going to be
`12 my answer here. I -- I -- you know, nothing --
`13 in thinking after answering your question first,
`14 and, actually, my mind kind of ran through the
`15 rest of the prior art there, and nothing stands
`16 out as to me taking credit for I found this.
`17 Q. So your answer would be you can't
`18 recall any specific prior art reference that you
`19 found on your own?
`20 A. At the moment, I do not -- I have not
`21 thought about that, given it any -- um, any sort
`22 of priority to think of that, so, no.
`23 Q. So your answer is you cannot recall
`24 any specific piece of prior art --
`25 A. That --
`
`Page 19
`
`Page 21
`
`1 of your question, and I'm sorry. It seems
`2 almost if you're talking and you're looking down
`3 at notes or something, when you look down, it
`4 gets more muffled if that helps you in any way.
`5 Q. All right.
`6 A. So I just -- okay.
`7 Q. Sure. Okay. Good to know.
`8 Uh, the Itou patent --
`9 A. Yeah.
`10 Q. -- was that something that you found
`11 on your own, or did Robins Kaplan provide that
`12 to you?
`13 A. Well, that's a good question. I have
`14 seen Itou before. Um, it's not an uncommon
`15 patent in this -- in the world, in the area
`16 we're talking about. I had seen it before, and
`17 actually I ran across a paper copy of it just
`18 the other day.
`19 We have recently moved into the house
`20 we're in now, and I was going through an office
`21 with 30 years' worth of documents and tossing
`22 things, and Itou just happened to be one of
`23 them, um, but I -- here again, I don't recall
`24 whether or not I chose Itou at the early stages
`25 of the -- of this research and building the --
`
`1 Q. -- you found on your own?
`2 A. That is my answer, yeah.
`3 Q. In connection with putting together
`4 your declarations for this matter, did you talk
`5 with a Dr. Brecker?
`6 A. He was on a phone call that we had,
`7 um, and so -- and there were multiple people on
`8 the call. It was a conference call, so we did
`9 exchange a few direct comments with one another.
`10 Q. Was that before you signed the
`11 declarations that you submitted in this matter?
`12 A. I -- yes, yes.
`13 Q. Approximately, how long was that
`14 phone call?
`15 A. Oh, it wasn't -- it wasn't very long.
`16 Uh, I -- I don't know, 15 minutes, 10 minutes or
`17 something and -- and my participation in it was
`18 very small. There was a lot of talking going
`19 on, and Dr. Brecker and I said hello and sort of
`20 remembered running into each other at various
`21 meetings.
`22 We both routinely attend the TCT
`23 meeting and the American College of Cardiology,
`24 the PCR in Europe, and ACC meetings, and so on,
`25 and so it was mostly exchanging pleasantries.
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`6 (Pages 18 - 21)
`888-391-3376
`
`

`

`Page 22
`
`Page 24
`
`1 Q. Okay. So would it be fair to say
`2 that during this call, you and Dr. Brecker
`3 didn't really talk about much substantive --
`4 THE COURT REPORTER: I'm sorry.
`5 Could you repeat that question,
`6 please?
`7 MR. KOHLHEPP: Sure.
`8 BY MR. KOHLHEPP:
`9 Q. I said would it be fair to say that
`10 during this telephone call, you and Dr. Brecker
`11 did not discuss substantive things?
`12 MR. PINAHS: Dr. Hillstead, you can
`13 answer the question, but please do not and I
`14 will counsel you not to discuss the substance of
`15 the call with Dr. Brecker.
`16 THE WITNESS: So as the call was
`17 related to the subject matter here, as I said,
`18 there were multiple attorneys on the call and
`19 Dr. Brecker, um, subject matter was certainly
`20 discussed, but as the direct interaction between
`21 myself and Dr. Brecker was limited. I don't
`22 recall -- it wasn't as if the call was set up
`23 for me to ask him questions or him to ask me
`24 questions.
`25 BY MR. KOHLHEPP:
`
`Page 23
`
`1 Q. Prior to submitting your
`2 declarations, did you talk to Dr. Brecker on any
`3 other occasions?
`4 A. Did you say on other issues?
`5 Q. Any other times?
`6 MR. PINAHS: Objection.
`7 THE WITNESS: Okay. Any other time.
`8 Did it -- and to the best -- no.
`9 That was the only call that I -- that I had
`10 where I spoke to Dr. Brecker. I can't say
`11 categorically that he wasn't on another
`12 conference call, but I don't believe he was. I
`13 don't believe we ever had any other
`14 communications during the course of -- of this
`15 case.
`16 BY MR. KOHLHEPP:
`17 Q. Have you talked to Dr. Brecker since
`18 that call before you submitted your declaration?
`19 A. Have I talked to him you said?
`20 Q. Let me rephrase that question.
`21 A. Good.
`22 Q. In the time from when you submitted
`23 your declarations to now, have you talked to Dr.
`24 Brecker?
`25 A. No, no.
`
`1 Q. Do you recall talking to anyone else
`2 other than the attorneys from Robins Kaplan and
`3 Dr. Brecker in the course of preparing your
`4 declarations?
`5 A. And you mean about this case to
`6 anyone else during the course --
`7 Q. Correct.
`8 A. Oh, no, no.
`9 Q. Now, before signing your
`10 declarations, did you review the five GuideLiner
`11 patents?
`12 A. Well, I think what -- that's already
`13 been answered. I -- yes. I did review those
`14 patents, um, before signing my declaration, yes.
`15 Q. Did you review the claims of those
`16 patents?
`17 A. Certainly if I'm reviewing a patent,
`18 I will be looking at claims, yes.
`19 Q. Approximately, how much time did you
`20 spend preparing the declarations for these
`21 matters?
`22 A. Uh, that's a good question, and I
`23 have not sat around and tallied that up. Quite
`24 a bit. There's a -- I'll go back to what I said
`25 earlier. I don't know if it was the 13 or so
`
`Page 25
`1 declarations that we have here in -- uh, in this
`2 case. That takes a lot of time, so it was
`3 pretty busy activity pulling together all that
`4 we put together before signing them, so I don't
`5 know. It was over a couple months it seems
`6 like. A lot of work.
`7 Q. Was it in the ballpark of 50 hours, a
`8 hundred hours?
`9 A. Probably between 50 and a hundred
`10 somewhere. Actually, I think I owe some -- um,
`11 some invoicing still but . . .
`12 I mean if you need to -- if that's
`13 something that is really important, I could go
`14 find out. I could go look at billing, but I
`15 don't typically -- um, I don't typically keep
`16 track of -- of that.
`17 Q. What hourly rate are you charging for
`18 these proceedings?
`19 A. I'm sorry.
`20 Once again, I lost the first part of
`21 that. You were looking down and that --
`22 Q. Sorry.
`23 A. -- muffled it some.
`24 Q. My apologies.
`25 What hourly -- what hourly rate are
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`7 (Pages 22 - 25)
`888-391-3376
`
`

`

`Page 26
`
`Page 28
`
`1 you charging for this proceeding?
`2 A. Uh, six-fifty per hour.
`3 Q. Approximately, how much have you, um,
`4 invoiced so far for these matters?
`5 A. Oh, gosh. I just -- I don't know. I
`6 don't look. I have a bookkeeper that handles my
`7 -- you know, I'm incorporated, so I -- I put
`8 together the billing invoice. She takes the
`9 checks when they come in and -- and does the
`10 bookkeeping. I don't -- I really don't recall.
`11 Q. Can you provide an estimate?
`12 A. Uh, I don't know. Uh, I really don't
`13 know. I could go look and get you the number
`14 later but an estimate over the last year of time
`15 though, I . . .
`16 Q. Is it over a hundred thousand?
`17 A. Probably not. Um, maybe --
`18 Q. Over 50 --
`19 A. Yeah. Maybe between 50 and a
`20 hundred, something like that, yeah.
`21 Q. I wanted to ask you what you did in
`22 preparation for this deposition.
`23 Did you meet with Medtronic's
`24 counsel?
`25 A. Not physically. Uh, we're all
`
`1 Uh, is this prior to institution or
`2 after or . . .
`3 Q. Correct. It would have been briefs
`4 filed by Teleflex prior to institution.
`5 A. Um, well, it seems like I may have
`6 seen something there, but I certainly didn't
`7 spend a great deal of time. And, now, I do
`8 recall, um, I think seeing some related
`9 documents, but nothing I spent any great deal of
`10 time on or could quote from or anything.
`11 Q. Did you review any of the
`12 declarations filed by Teleflex experts prior to
`13 institution?
`14 A. Again, I lost the first part, but I
`15 think you said did I review the declaration or
`16 look at a declaration by a Teleflex expert?
`17 Q. Correct.
`18 A. Yeah. I did see that at some point
`19 in the process. Um, Keith I believe was his
`20 name.
`21 Q. Did you review the Patent Trial and
`22 Appeal Board's institution decisions in these
`23 matters?
`24 A. The patent file and what was your
`25 next word?
`
`Page 27
`
`Page 29
`
`1 getting pretty adept at these Zoom calls,
`2 so . . .
`3 Q. So you did meet with the attorneys
`4 from Robins Kaplan remotely in preparation for
`5 this deposition?
`6 A. Yes.
`7 Q. Approximately, how much time did you
`8 spend meeting with the Robins attorneys
`9 preparing for this deposition?
`10 A. I don't know. It seems like we did,
`11 uh, three or four -- three-and-a-half, something
`12 like -- maybe three or four zoom calls that
`13 they -- five or six hours in a day doing that.
`14 Q. Other than the Robins Kaplan
`15 attorneys, are there people you spoke with in
`16 preparation for this deposition?
`17 A. Um, not really. Um, I can't -- I
`18 really can't think of any.
`19 Q. Prior to this deposition, did you
`20 review any of the preliminary responses that
`21 Teleflex filed in these matters?
`22 A. Please repeat that?
`23 Q. Did you review any of the preliminary
`24 responses that Teleflex filed in these matters?
`25 A. Preliminary responses?
`
`1 Q. Did you review the institution
`2 decisions in these IPRs?
`3 A. Yeah, sort of. It's kind of boring.
`4 Uh, I don't -- I did review it superficially,
`5 but it wasn't anything I spent a great deal of
`6 time on.
`7 Q. Okay. Did you review the transcript
`8 from the deposition of Dr. Brecker?
`9 A. Yes. I did review that in -- the
`10 transcript, yep, the written transcript.
`11 Q. Did you review any video of that
`12 deposition?
`13 A. No.
`14 Q. Is there anything else that you
`15 reviewed that we haven't talked about in
`16 preparation for this deposition?
`17 A. I don't believe so. I think
`18 everything that I reviewed that contributed to
`19 my opinion would be attachments or exhibits to
`20 my reports.
`21 Q. So you've worked as an expert in
`22 patent disputes before, correct?
`23 A. Yes, I have.
`24 Q. Approximately, how many times?
`25 A. Um, in patent disputes.
`
`www.veritext.com
`
`Paradigm, A Veritext Company
`
`8 (Pages 26 - 29)
`888-391-3376
`
`

`

`Page 30
`1 Would you -- would that include both
`2 the trade secrets and infringement and IPRs and
`3 European EPO oppositions, that sort of thing?
`4 Q. Sure.
`5 A. All of those?
`6 I don't know. Maybe, um, ten times
`7 or so, eight or ten times. Maybe more. Around
`8 that though.
`9 Q. If you were asked, would you be able
`10 to provide a list of those matters?
`11 A. Yeah, probably. Uh, I wouldn't be
`12 able to give you much detail but, um, certainly,
`13 yeah.
`14 Q. To your knowledge, has your opinion
`15 as an expert ever been excluded?
`16 A. You mean like through a Daubert
`17 motion?
`18 Q. Correct, or something similar?
`19 A. Something similar?
`20 The -- the only anything I can recall
`21 was there and it was common to all of us was
`22 Justice Allison Burroughs -- oh, I'm hearing an
`23 echo of my own voice. I'm sorry. I thought it
`24 was counsel, uh, objecting. This suddenly just
`25 started happening. My own voice is coming back
`
`Page 32
`1 infringement cases, um, yeah, similar to what
`2 we're doing here.
`3 Q. Anything else you can think of?
`4 A. You know, I'm trying to -- to look
`5 through that. I've been doing this for about 25
`6 years or more, 30 years, so the -- it seems like
`7 the first time I had anything to do with
`8 Medtronic as their client -- no. Actually, I
`9 was oppos

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket